Cargando…

Oral Fibrosis and Oral Cancer: From Molecular Targets to Therapeutics

Detalles Bibliográficos
Autores principales:	Hsieh, Pei-Ling, Yu, Cheng-Chia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181066/ https://www.ncbi.nlm.nih.gov/pubmed/35682789 http://dx.doi.org/10.3390/ijms23116110

Ejemplares similares

miR‐200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2
por: Liao, Yi‐Wen, et al.
Publicado: (2018)

The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis
por: Hsieh, Pei-Ling, et al.
Publicado: (2022)

LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis
por: Lee, Yu-Hsien, et al.
Publicado: (2021)

MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells
por: Hsieh, Pei-Ling, et al.
Publicado: (2020)

Early diagnosis of oral submucous fibrosis is a boon in the prevention of oral cancer
por: Pal, U. S.
Publicado: (2021)

Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition
por: Lin, Ching-Yeh, et al.
Publicado: (2019)

Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis
por: Yu, Cheng-Chia, et al.
Publicado: (2021)

Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation
por: Hu, Fang-Wei, et al.
Publicado: (2017)

LINC00312/YBX1 Axis Regulates Myofibroblast Activities in Oral Submucous Fibrosis
por: Yu, Chuan-Hang, et al.
Publicado: (2020)

MiR-424/TGIF2-Mediated Pro-Fibrogenic Responses in Oral Submucous Fibrosis
por: Chou, Ming-Yung, et al.
Publicado: (2023)

miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
por: Lin, Shih-Shen, et al.
Publicado: (2018)

Positive Feedback Loop of SNAIL-IL-6 Mediates Myofibroblastic Differentiation Activity in Precancerous Oral Submucous Fibrosis
por: Peng, Chih-Yu, et al.
Publicado: (2020)

Editorial of Special Issue “Oral Cancer: From Pathophysiology to Novel Therapeutic Approaches”
por: Vincent-Chong, Vui King
Publicado: (2023)

Butylidenephthalide Abrogates the Snail-Induced Cancer Stemness in Oral Carcinomas
por: Chen, Pei-Yin, et al.
Publicado: (2022)

Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells
por: Lin, Che-Yi, et al.
Publicado: (2017)

miR-509 inhibits cancer stemness properties in oral carcinomas via directly targeting PlK1
por: Lu, Ming-Yi, et al.
Publicado: (2022)

miR-21 promotes the fibrotic properties in oral mucosa through targeting PDCD4
por: Liao, Yi-Wen, et al.
Publicado: (2022)

Molecular Imaging in Targeted Therapeutics
por: Wang, Yuebing, et al.
Publicado: (2018)

Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells
por: Lin, Che-Yi, et al.
Publicado: (2018)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

Targeting oral cancer epigenome via LSD1
por: Bais, Manish V.
Publicado: (2017)

Oral Cancer and Oral Potentially Malignant Disorders
por: Farah, Camile S., et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Oral Rehabilitation from Oral and Dental Diseases
por: Ogino, Yoichiro
Publicado: (2022)

Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets
por: Qin, Xiaofeng, et al.
Publicado: (2023)

Role of oral and maxillofacial surgeons in treating oral cancer
por: Seok, Hyun
Publicado: (2022)

Molecular markers as therapeutic targets in lung cancer
por: Tseng, Hsin-Hui, et al.
Publicado: (2013)

Oral Biology, Oral Pathology, and Oral Treatments
por: Nammour, Samir, et al.
Publicado: (2016)

Cardiac Fibrosis: Chronic Inflammatory Disease and Promising Therapeutic Target
por: Okamoto, Ryuji
Publicado: (2022)

Targeting LncRNA HOTAIR suppresses cancer stemness and metastasis in oral carcinomas stem cells through modulation of EMT
por: Lu, Ming-Yi, et al.
Publicado: (2017)

Oral Prevention and Management of Oral Healthcare
por: Vozza, Iole
Publicado: (2021)

Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosis
por: Yu, Cheng-Chia, et al.
Publicado: (2016)

Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide
por: Hu, Zhenhua, et al.
Publicado: (2020)

Ultrasound Is Beneficial to Determine Lymphadenopathy in Oral Cancer Patients after Radiotherapy
por: Cheng, Ping-Chia, et al.
Publicado: (2023)

Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis
por: Yuan, Yao, et al.
Publicado: (2016)

Fluorescence visualization as an auxiliary method to detect oral potentially malignant disorders and oral cancer
por: Tomo, Saygo, et al.
Publicado: (2022)

Commentary on Elective versus therapeutic neck dissection in node-negative oral cancer
por: Kuriakose, Moni Abraham
Publicado: (2015)

The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Cheng, Yali, et al.
Publicado: (2021)

Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review
por: You, Jie-Ru, et al.
Publicado: (2023)

Polyphenol-based targeted therapy for oral submucous fibrosis
por: Mehta, Chetan Hasmukh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jcuqc59a6prg0diujjfohg8ck8